_how-covid-19-pandemic-precautions-crushed-the-flu-season-preview-1.jpg "How COVID-19 pandemic precautions crushed the flu season from season covid 19 Video Screenshot Preview 1")
Gallery_how-covid-19-pandemic-precautions-crushed-the-flu-season-preview-3.jpg "How COVID-19 pandemic precautions crushed the flu season from season covid 19 Video Screenshot Preview 3")
Gallery_how-covid-19-pandemic-precautions-crushed-the-flu-season-preview-hqdefault.jpg "How COVID-19 pandemic precautions crushed the flu season from season covid 19 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 15 seconds
👁 View: 2K times
Play Audio:👁 View: 2K times
Description:
Global News
Global News
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_us-states-battle-new-covid-19-surge-as-flu-season-starts.webp "Al Jazeera English")
_evidence-medication-could-benefit-long-covid-sufferers.webp "Evidence is mounting a medication already used to treat opioid and alcohol dependence, could benefit people living with long covid. Queensland researchers have published world-first findings showing naltrexone restores the function of impaired cells from patients with the debilitating condition.")
_overlap-of-covid-19-and-flu-season-could-have-devastating-consequences-124-nbc-nightly-news.webp "NBC News")
⏲ 2 minutes 18 seconds 👁 41.4K
_staying-safe-this-holiday-season-124-covid-19-variants.webp "Johns Hopkins Medicine")
_flu-season-covid-19-and-vaccine-fatigue.webp "KXAN")
_covid-19-and-flu-set-to-peak-over-holiday-season-in-ontario-moore-urges-vaccinations.webp "CP24")
⏲ 4 minutes 3 seconds 👁 1.4K
_novavax-and-sanofi-strike-multi-billion-dollar-deal-for-co-commercialization-of-covid-19-vaccine.webp "Novavax has signed a multi-billion dollar deal with French drugmaker Sanofi to co-commercialize Novavax's protein-based COVID-19 vaccine starting in 2025. Sanofi will pay Novavax an upfront payment of $500 million and up to $700 million in additional payments based on development, regulatory, and launch milestones. Sanofi will also take a less than 5% equity stake in Novavax and provide royalty payments on future vaccine sales. The deal allows Sanofi to develop combination shots using Novavax's COVID vaccine with Sanofi's flu shot or other vaccines in its portfolio.")
⏲ 0:45 👁 515K
_what-covid-19-might-mean-for-flu-season.webp "extratv")
_us-states-battle-new-covid-19-surge-as-flu-season-starts.jpg)
_evidence-medication-could-benefit-long-covid-sufferers.jpg)
_overlap-of-covid-19-and-flu-season-could-have-devastating-consequences-124-nbc-nightly-news.jpg)
_staying-safe-this-holiday-season-124-covid-19-variants.jpg)
_flu-season-covid-19-and-vaccine-fatigue.jpg)
_covid-19-and-flu-set-to-peak-over-holiday-season-in-ontario-moore-urges-vaccinations.jpg)
_novavax-and-sanofi-strike-multi-billion-dollar-deal-for-co-commercialization-of-covid-19-vaccine.jpg)
_what-covid-19-might-mean-for-flu-season.jpg)
![[+]](/images/menu.gif){kind=small}